Below is information about SANDOZ GLOBAL HEADQUARTERS from a variety of sources. Please take a look at the materials that our team has selected for you.


Office Locations | Sandoz

    https://www.sandoz.com/about-us/contact-us/office-locations
    Find information on our research locations and corporate offices around the world.

Contact Us | Sandoz

    https://www.sandoz.com/about-us/contact-us
    At Sandoz, we value your feedback as we are committed to continuously improving our products and services and providing greater value to our patients, customers and other stakeholders. Germany Sandoz International GmbH Industriestrasse 25 83607 Holzkirchen Germany Tel: +49 8024 476 0 Fax: +49 89 8024 476 1290 Monday - Friday

Sandoz invests in major expansion of global …

    https://www.sandoz.com/news/media-releases/sandoz-invests-major-expansion-global-headquarters-holzkirchen-germany
    Holzkirchen, August 29, 2017 — Sandoz, the generic pharmaceuticals and biosimilars division of Novartis, announced today that it will further expand its global headquarters in Holzkirchen, near Munich. The expected investment will amount to approximately USD 50m. Sandoz will begin construction of two additional office buildings at the company ...

Sandoz

    https://www.sandoz.com/
    We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine. The information center provides a central hub for news, guidance and resources. Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz.

Contact - Sandoz Corporation

    http://www.sandozcorp.com/company/en/contact-us/
    Global Partners; Contact; CONTACT US. 137-927 Sandoz II Bldg. 57 Hyoreong-ro 52-gil, Seocho-gu, Seoul, Korea. TEL 02.582.4030 FAX 02.582.4033 [email protected] www.sandozcorp.com. Your Name (required) Your Email (required) Subject. Your Message. TEL +82 2 582 4030 FAX 02 582 4033 .

About Us | Sandoz US

    https://www.us.sandoz.com/about-us
    Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives. In this section. Who We Are We are a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide.

About Us - Sandoz Corporation

    http://www.sandozcorp.com/company/en/about-us/
    Sandoz Corporation pursues the vision of becoming a global company that embraces the whole world with honesty and customer-centered management. OUR HISTORY Toward the dream of embracing the whole world with honesty and customer-centered management. TEL +82 2 582 4030 FAX 02 582 4033 .

Who We Are | Sandoz

    https://www.sandoz.com/about-us/who-we-are
    We are a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide. ... Our Purpose and Ambition At Sandoz, we discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high-quality medicine. Innovation ...

Sandoz Company Profile - Office Locations, Competitors, …

    https://craft.co/sandoz-international
    Basel, April 6, 2022 — Sandoz today announces the extension and expansion until January 31, 2025 of its strategic collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR).

Contact Us | Sandoz US

    https://www.us.sandoz.com/about-us/contact-us
    If you would like to report a side effect, or adverse event, involving a Sandoz medicine in the US, please contact us by calling 1-800-525-8747. Product- and Customer-related Inquiries If you are a patient, doctor or health care provider and have a question concerning one of our generic drugs or biosimilars, please call 1-800-525-8747.

Did you find the information you need about SANDOZ GLOBAL HEADQUARTERS?

We hope you found all the information about SANDOZ GLOBAL HEADQUARTERS you were looking for and more.